BAWEI
837023
XI'AN WONDER
836419
Jiangsu Tiangong Technology
920068
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
CN Stock MarketDetailed Quotes
300302 Toyou Feiji Electronics
- 13.89
- -0.35-2.46%
Market Closed May 15 15:00 CST
6.66BMarket Cap-21.47P/E (TTM)
14.27High13.85Low91.26KlotVolume14.27Open14.24Pre Close127.59MTurnover2.47%Turnover RatioLossP/E (Static)479.26MShares23.2752wk High6.41P/B5.12BFloat Cap8.5352wk Low17.09Limit Up368.89MShs Float40.60Historical High11.39Limit Down2.95%Amplitude2.21Historical Low--Dividend TTM13.98Avg Price56.61KlotAsk--Div YieldTTM100Lot Size31.76KlotBid
Toyou Feiji Electronics Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -49.30%47.52M | 3.89%364.73M | 22.40%303.76M | 24.52%252.08M | -36.97%93.72M | -19.35%351.07M | -16.55%248.17M | -12.05%202.45M | 6.38%148.7M | 11.35%435.29M |
| Operating revenue | -49.30%47.52M | 3.89%364.73M | 22.40%303.76M | 24.52%252.08M | -36.97%93.72M | -19.35%351.07M | -16.55%248.17M | -12.05%202.45M | 6.38%148.7M | 11.35%435.29M |
| Other operating revenue | ---- | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | --0 |
| Total operating cost | -22.08%73.44M | -1.96%392.23M | 2.49%285.19M | 5.01%214.25M | -25.63%94.25M | -1.57%400.08M | 0.93%278.27M | 0.82%204.04M | 7.90%126.73M | 5.98%406.45M |
| Operating cost | -46.93%27.63M | -6.90%212.98M | 3.57%158.17M | 5.53%127.87M | -41.47%52.06M | -3.34%228.78M | -6.39%152.72M | -5.84%121.17M | 7.75%88.95M | 18.11%236.68M |
| Operating tax surcharges | 53.93%1.21M | 26.92%3.45M | 17.93%3.1M | 4.70%2.69M | -23.89%785.68K | -41.07%2.72M | -2.44%2.63M | 22.99%2.57M | -24.82%1.03M | 43.96%4.62M |
| Operating expense | -9.95%7.31M | -3.28%36.32M | -9.43%25.39M | -6.11%16.97M | -11.90%8.12M | 13.70%37.55M | 14.11%28.03M | 11.65%18.07M | 24.02%9.22M | -21.93%33.03M |
| Administration expense | 25.07%14.63M | 7.16%52.89M | 0.12%35.44M | 2.26%23.63M | 14.37%11.7M | 1.80%49.36M | 6.59%35.4M | 6.76%23.11M | -4.88%10.23M | -16.72%48.49M |
| Financial expense | 191.40%4.52M | 34.60%10.31M | -9.87%6.1M | -3.50%4.9M | 18.65%1.55M | -40.51%7.66M | 6.80%6.77M | 12.21%5.08M | -44.08%1.31M | 41.36%12.87M |
| -Interest expense (Financial expense) | 126.92%4.81M | 29.07%10.94M | 30.96%7.83M | 36.05%5.42M | -3.93%2.12M | -11.34%8.48M | -15.60%5.98M | -18.66%3.98M | -16.64%2.21M | -13.01%9.56M |
| -Interest Income (Financial expense) | 55.15%-250.37K | 11.37%-1.61M | 20.29%-1.08M | 1.22%-860.31K | -50.71%-558.25K | 5.25%-1.82M | -22.27%-1.35M | -17.61%-870.96K | 0.76%-370.42K | -4.33%-1.92M |
| Research and development | -9.44%18.14M | 3.06%76.27M | 8.10%56.99M | 12.20%38.2M | 25.28%20.03M | 4.58%74M | 15.23%52.72M | 16.38%34.05M | 23.03%15.99M | 0.70%70.76M |
| Credit Impairment Loss | 112.23%440.25K | 122.85%2.45M | 96.08%-1.45M | 84.23%-5.96M | -71.24%-3.6M | 57.30%-10.71M | -119.33%-37.04M | -74.26%-37.81M | 57.96%-2.1M | -577.63%-25.08M |
| Asset Impairment Loss | ---- | -201.82%-260.88M | ---- | ---- | ---- | -9,535.57%-86.44M | ---- | ---- | --0 | 93.70%-897.06K |
| Other net revenue | -104.91%-14.44K | -84.72%-251.82M | 125.99%16.86M | 113.18%7.44M | 102.62%293.85K | -160.65%-136.32M | -171.56%-64.85M | -98.47%-56.41M | 11.58%-11.2M | -97.97%-52.3M |
| Fair value change income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Invest income | -136.52%-672.71K | 97.65%-1.26M | 130.69%12.21M | 128.05%8.14M | 111.66%1.84M | -38.07%-53.83M | -157.47%-39.78M | -206.22%-29.03M | -89.08%-15.81M | -98.00%-38.99M |
| -Including: Investment income associates | -143.64%-803.89K | 97.65%-1.26M | 130.63%12.21M | 127.98%8.14M | 111.66%1.84M | -38.27%-53.9M | -157.93%-39.85M | -206.97%-29.1M | -89.08%-15.81M | -97.97%-38.99M |
| Asset deal income | ---- | -66.09%14.73K | ---- | ---- | ---- | 42.58%43.43K | -44.02%9.92K | --9.92K | --2.02K | 2,877.46%30.46K |
| Other revenue | -89.37%218.01K | -46.15%7.87M | -49.00%6.1M | -49.48%5.26M | -69.42%2.05M | 15.67%14.61M | 205.50%11.96M | 278.41%10.41M | 863.32%6.71M | 12.58%12.63M |
| Operating profit | -11,046.49%-25.93M | -50.71%-279.32M | 137.31%35.42M | 178.03%45.26M | -102.16%-232.63K | -689.67%-185.33M | -4,211.22%-94.96M | -9,200.01%-58M | 11.46%10.78M | -23.45%-23.47M |
| Add:Non operating Income | 729.34%935 | 59.61%211.85K | 62.18%211.76K | -87.20%11.62K | -88.16%112.74 | -53.93%132.73K | -48.83%130.57K | -63.96%90.78K | -99.54%952.49 | -1.18%288.1K |
| Less:Non operating expense | ---- | 26.65%683.21K | -94.88%26.74K | 146.20%23.6K | ---- | 246.59%539.43K | 313.32%522.82K | -59.57%9.59K | --0 | -60.36%155.64K |
| Total profit | -11,051.49%-25.93M | -50.64%-279.79M | 137.35%35.61M | 178.12%45.25M | -102.16%-232.52K | -695.90%-185.73M | -4,497.66%-95.35M | -14,543.60%-57.92M | 9.37%10.78M | -22.10%-23.34M |
| Less:Income tax cost | 112.44%389.42K | -80.38%867.06K | 121.07%4.26M | 100.74%98.24K | -316.77%-3.13M | 232.43%4.42M | -268.75%-20.22M | -319.05%-13.36M | 102.95%1.44M | 52.57%-3.34M |
| Net profit | -1,008.38%-26.32M | -47.59%-280.65M | 141.73%31.35M | 201.33%45.15M | -68.96%2.9M | -850.77%-190.15M | -2,304.01%-75.13M | -1,695.61%-44.56M | 2.09%9.33M | -65.60%-20M |
| Net profit from continuing operation | -1,008.38%-26.32M | -47.59%-280.65M | 141.73%31.35M | 201.33%45.15M | -68.96%2.9M | -850.77%-190.15M | -2,304.01%-75.13M | -1,695.61%-44.56M | 2.09%9.33M | -65.60%-20M |
| Net income from discontinuing operating | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 |
| Less:Minority Profit | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 |
| Net profit of parent company owners | -1,008.38%-26.32M | -47.59%-280.65M | 141.73%31.35M | 201.33%45.15M | -68.96%2.9M | -850.77%-190.15M | -2,304.01%-75.13M | -1,695.61%-44.56M | 2.09%9.33M | -65.60%-20M |
| Earning per share | ||||||||||
| Basic earning per share | -1,015.00%-0.0549 | -48.32%-0.5841 | 141.93%0.0652 | 201.74%0.0937 | -68.91%0.006 | -858.15%-0.3938 | -2,321.43%-0.1555 | -1,715.79%-0.0921 | 3.21%0.0193 | -65.06%-0.0411 |
| Diluted earning per share | -1,015.00%-0.0549 | -48.32%-0.5841 | 141.93%0.0652 | 201.74%0.0937 | -68.91%0.006 | -858.15%-0.3938 | -2,321.43%-0.1555 | -1,715.79%-0.0921 | 3.21%0.0193 | -65.06%-0.0411 |
| Other composite income | -184.20%-107.91K | -7.25%1.11M | -135.51%-793.49K | -82.95%461.37K | 113.31%128.15K | -80.45%1.2M | 43.37%2.23M | 326.48%2.71M | -3,339.72%-962.69K | 14,002.90%6.13M |
| Other composite income of parent company owners | -184.20%-107.91K | -7.25%1.11M | -135.51%-793.49K | -82.95%461.37K | 113.31%128.15K | -80.45%1.2M | 43.37%2.23M | 326.48%2.71M | -3,339.72%-962.69K | 14,002.90%6.13M |
| Total composite income | -973.47%-26.43M | -47.94%-279.54M | 141.92%30.56M | 208.98%45.61M | -63.86%3.03M | -1,262.05%-188.95M | -1,567.45%-72.9M | -1,321.17%-41.85M | -8.16%8.37M | -14.45%-13.87M |
| Total composite income of parent company owners | -973.47%-26.43M | -47.94%-279.54M | 141.92%30.56M | 208.98%45.61M | -63.86%3.03M | -1,262.05%-188.95M | -1,567.45%-72.9M | -1,321.17%-41.85M | -8.16%8.37M | -14.45%-13.87M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.